TLDR Men with enlarged prostates often have more severe baldness.
In 1998, a study involving 225 patients with benign prostatic hyperplasia (BPH) and 160 controls investigated the link between BPH and male pattern baldness. The study found that those with BPH had a higher severity of baldness (median grade IV) compared to the control group (median grade III), with a significant difference (P <0.001). Additionally, 53.8% of the BPH group had a baldness grade of IV or higher, compared to 36.9% in the control group (P <0.01), and a higher incidence of inherited baldness was observed in the BPH group (31.6% vs. 12.5% in controls, P <0.001). However, no correlation was found between the severity of baldness and the International Prostate Symptom Score. The study concluded that there is a strong association between BPH and male pattern baldness, which could lead to cross-screening and combined treatment strategies for both conditions.
19 citations,
January 1997 in “Endocrinology” Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.
30 citations,
March 1996 in “British Journal of Dermatology” 61 citations,
September 1994 in “The Journal of Clinical Endocrinology and Metabolism” 
101 citations,
April 1994 in “Baillière's clinical endocrinology and metabolism” 5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.
187 citations,
January 1994 in “The New England Journal of Medicine” Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.
1040 citations,
October 1992 in “The New England Journal of Medicine” Finasteride effectively treats BPH but may increase sexual dysfunction risk.
40 citations,
February 1992 in “The Journal of Clinical Endocrinology and Metabolism” Taking finasteride pills and using minoxidil lotion together can help grow hair.
57 citations,
January 1986 in “The Prostate” The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.
December 2002 in “대한피부과학회지” Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.
1 citations,
January 2002 in “Journal of Clinical Dermatology” Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.
